Publication | Open Access

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

Relapsing-remitting Multiple SclerosisNeurological DisorderMulticentre StudyImmunologyClinical TrialsClinical NeurologyNeurological ProgressNeurologyMultiple SclerosisMg Glatiramer AcetateMedicine